Endoscopic and Histologic Response and Remission in Inflammatory Bowel Disease Patients Initiating Vedolizumab

被引：2
|
作者：
Christensen, Britt [1 ]
Rubin, David T. [1 ]
Goeppinger, Sarah [1 ]
Colman, Ruben J. [1 ]
Yarur, Andres [1 ]
Hirsch, Ayal [1 ]
Bocheneck, Ashley [1 ]
Wichmann, Alana [1 ]
Sakuraba, Atsushi [2 ]
Cohen, Russell [1 ]
Siddiqui, Dania [1 ]
机构：
[1] Univ Chicago Med, Chicago, IL USA
[2] Univ Chicago, Chicago, IL 60637 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2015年 / 110卷
关键词：
D O I：
10.14309/00000434-201510001-01843
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1843
引用
收藏
页码：S783 / S784
页数：2
相关论文
共 50 条
  • [1] Fecal calprotectin is an early predictor of endoscopic response and histologic remission after the start of vedolizumab in inflammatory bowel disease
    Pauwels, Renske W. M.
    van der Woude, Christien J.
    Erler, Nicole S.
    de Vries, Annemarie C.
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2020, 13
  • [2] Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn's Disease
    Lowenberg, Mark
    Vermeire, Severine
    Mostafavi, Nahid
    Hoentjen, Frank
    Franchimont, Denis
    Bossuyt, Peter
    Hindryckx, Pieter
    Rispens, Theo
    de Vries, Annick
    van der Woude, C. Janneke
    Berends, Sophie
    Ambarus, Carmen A.
    Mathot, Ron
    Clasquin, Esme
    Baert, Filip
    D'Haens, Geert
    [J]. GASTROENTEROLOGY, 2019, 157 (04) : 997 - +
  • [3] Vedolizumab trough concentrations are associated with endoscopic response in patients with inflammatory bowel disease
    Chao, C. -Y.
    Restellini, S.
    Lemieux, C.
    Germain, P.
    Bitton, A.
    Lakatos, P. L.
    Wild, G.
    Seidman, E.
    Bessissow, T.
    Afif, W.
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S367 - S368
  • [4] Clinical outcomes of vedolizumab withdrawal in inflammatory bowel disease for patients in histological remission
    Blad, William
    Whitley, Lisa
    Harrow, Paul
    [J]. GUT, 2023, 72 (SUPPL_2) : A87 - A88
  • [5] Vedolizumab trough levels at Week 6 predict endoscopic and clinical remission in inflammatory bowel disease
    Hanzel, J.
    Sever, N.
    Ferkolj, I.
    Stabuc, B.
    Smrekar, N.
    Kozelj, M.
    Novak, G.
    Gils, A.
    Drobne, D.
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S414 - S414
  • [6] Early vedolizumab trough levels predict combined endoscopic and clinical remission in inflammatory bowel disease
    Hanzel, Jurij
    Sever, Nejc
    Ferkolj, Ivan
    Stabuc, Borut
    Smrekar, Natasa
    Kurent, Tina
    Kozelj, Matic
    Novak, Gregor
    Compernolle, Griet
    Tops, Sophie
    Gils, Ann
    Drobne, David
    [J]. UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2019, 7 (06) : 741 - 749
  • [7] VEDOLIZUMAB TROUGH LEVELS AT WEEK 6 PREDICT ENDOSCOPIC AND CLINICAL REMISSION IN INFLAMMATORY BOWEL DISEASE
    Hanzel, Jurij
    Sever, Nejc
    Ferkolj, Ivan
    Stabuc, Borut
    Smrekar, Natasa
    Kozelj, Matic
    Novak, Gregor
    Gils, Ann
    Drobne, David
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S819 - S819
  • [8] Maintenance Adalimumab Concentrations Are Associated with Biochemical, Endoscopic, and Histologic Remission in Inflammatory Bowel Disease
    Juncadella, Anna
    Papamichael, Konstantinos
    Vaughn, Byron P.
    Cheifetz, Adam S.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (11) : 3067 - 3073
  • [9] Maintenance Adalimumab Concentrations Are Associated with Biochemical, Endoscopic, and Histologic Remission in Inflammatory Bowel Disease
    Anna Juncadella
    Konstantinos Papamichael
    Byron P. Vaughn
    Adam S. Cheifetz
    [J]. Digestive Diseases and Sciences, 2018, 63 : 3067 - 3073
  • [10] Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel Diseases
    Yarur, Andres J.
    Bruss, Alexandra
    Naik, Snehal
    Beniwal-Patel, Poonam
    Fox, Caroline
    Jain, Anjali
    Berens, Brandon
    Patel, Amir
    Ungaro, Ryan
    Bahur, Bayda
    Dubinsky, Marla
    Stein, Daniel J.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (06) : 1651 - 1659
12345